Navigation Links
Stereotaxis Reports Fourth Quarter 2008 Financial Results
Date:2/26/2009

65,173 39,298,809 Cost of revenue System 3,233,985 2,954,061 12,008,090 10,978,108 Disposables, service and accessories 693,558 764,897 2,169,700 2,497,459 Inventory impairment - - - 1,870,653 Total cost of revenue 3,927,543 3,718,958 14,177,790 15,346,220 Gross margin 8,198,941 6,535,905 26,187,383 23,952,589 Operating expenses: Research and development 3,561,488 5,996,138 17,422,828 25,471,809 Sales and marketing 5,363,663 8,287,708 28,660,663 29,021,117 General and administration 5,663,051 4,589,694 21,121,164 18,701,726 Total operating expenses 14,588,202 18,873,540 67,204,655 73,194,652 Operating loss (6,389,261) (12,337,635) (41,017,272) (49,242,063) Interest income 29,205 258,859 194,870 1,471,503 Interest expense (1,131,965) (134,455) (3,063,572) (350,954) Net loss $(7,492,021) $(12,213,231) $(43,885,974) $(48,121,514) Net loss per common share: Basic and diluted $(0.20) $(0.34) $(1.20) $(1.34) Weighted average shares used in computing net loss per common share: Basic and diluted 36,714,618 36,331,376 36,585,086 35,793,973 STEREOTAXIS, INC. BALANCE SHEETS December 31, December 31, 2008 2007 (Unaudited) Assets Current Assets: Cash and cash equivalents $30,355,657 $17,022,20
'/>"/>
SOURCE Stereotaxis, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine news :

1. Stereotaxis Annouces First CTO Crossing Procedure With RF PowerAssert(TM) Magnetic Guidewire
2. Stereotaxis to Raise $20 Million in Registered Direct Offering of Common Stock and Warrants
3. Stereotaxis Reports Third Quarter 2008 Financial Results
4. Stereotaxis Announces New Management Appointment
5. Stereotaxis Reports Record Second Quarter Revenue
6. Stereotaxis Announces Second Quarter 2008 Earnings Release Date and Conference Call
7. Stereotaxis Magnetic Navigation System Used to Successfully Treat an Inoperable Congenital Heart Defect in a 10-Year Old Patient
8. Stereotaxis Reports Record First Quarter Orders
9. Stereotaxis to Present at the Deutsche Bank 33rd Annual Health Care Conference
10. Stereotaxis Niobe Magnetic Navigation Systems Perform Approximately 15,000 Cases
11. Stereotaxis Appoints Senior Vice President of Global Marketing and General Manager for Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 23, 2015 AngelWeddingDress, the ... of 2015 maternity wedding dresses. View website ... are looking for maternity wedding dresses online for a ... gowns with high quality for them. Its maternity wedding ...
(Date:1/22/2015)... Dallas, TX (PRWEB) January 22, 2015 ... the issue of experience and person-centeredness in the long-term ... moving towards action across the continuum. The paper, “The ... the Continuum,” engages perspectives and practices of the patient, ...
(Date:1/22/2015)... January 22, 2015 For over 20 years, Dr. ... Oceanside and Vista area has treated just about every type ... injury circumstances. And for those same twenty-plus years, the team ... all those injuries with the best possible doctor. With ...
(Date:1/22/2015)... York, NY (PRWEB) January 22, 2015 ... College of Sports Medicine flagship journal Medicine & ... with L-Citrulline before exercise may help reduce gastrointestinal ... exercise. 1 , Participants in the double-blind, ...
(Date:1/22/2015)... Florida (PRWEB) January 22, 2015 IsoComforter, Inc. ... therapy machine with patented IsoTube design to treat specific body ... introduced the most progressive and easy to use patented cold ... post-operative and sports related orthopedic and muscle injuries. IsoComforter ...
Breaking Medicine News(10 mins):Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Industry Leading Chiropractor in Oceanside Joins the Doctors on Liens Network 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 2Health News:Study Shows Kyowa Hakko’s L-Citrulline May Help Reduce Gastrointestinal Injury During Strenuous Exercise 3Health News:IsoComforter Introduces Best of Class Cold Therapy Product to the Worldwide Market 2
... a naturally occurring chemical in the bodies of mice ... of the daylight they face. ,The researchers ... aggression in the animal during the short days of ... mice, when daylight increases in the summer. ...
... as a cure for infertility has made considerable progress. In ... sperm from adult stem cells, says Dr.Karim Nayerina, noted Iranian-born ... a professor of stem biology at the University of Newcastle ... coaxed the embryonic stem cells of mice into becoming mature ...
... are not made to recover two missing radiation detectors ... poisoning two of Asia's biggest rivers, a Japanese filmmaker ... of Japan Times who now runs an independent documentary-making ... and Unesco to mobilise search and recovery operations on ...
... found that exercise, particularly resistance training, rejuvenates muscle tissue ... skeletal muscle. ,Researchers examined gene expression profiles in ... age 65, before and after they did six months of ... samples from younger healthy men and women age 20 to ...
... majority of Europeans are in favour of a ban on ... showed Tuesday. ,Some 88 percent of citizens in ... indoor spaces, said a study by the European Commission, the ... said the broad support for anti-tobacco policies could help make ...
... target alcohol and alcohol addiction worldwide with a campaign ... ,European countries are the greatest consumers of alcohol, with ... country and Luxembourg more wine, according to WHO figures. ... biggest consumers of spirits. ,The move follows ...
Cached Medicine News:Health News:Researchers Find Estrogen Governs Genes That Affect Aggression 2Health News:Stem Cell Answer to Infertility in Five Years, Says Scientist 2Health News:Are Main Rivers in Himalayas Under Threat? 2Health News:Are Main Rivers in Himalayas Under Threat? 3Health News:Exercise can Slow Down the Aging Process in Elderly People 2
(Date:1/23/2015)... 23, 2015 Gem Pharmaceuticals announced today that the ... into the Company,s Phase 2 clinical trial.  This open-label ... lead compound, GPX-150 (an investigational medication), in approximately 30 ... Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
(Date:1/22/2015)... , Jan. 22, 2015  ViewRay™, a privately held medical ... an exclusive distributor agreement with ITOCHU Corporation (Tokyo Stock ... system for the treatment of cancer in ... is the world,s first and only MRI-guided radiation therapy ...
(Date:1/22/2015)... Jan. 22, 2015  ResMed Inc. (NYSE: RMD ) ... Revenue for the quarter was $423.0 million, a 10 percent ... 14 percent increase on a constant currency basis). Net income ... the quarter ended December 31, 2013. Diluted earnings per share ...
Breaking Medicine Technology:Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2ITOCHU Named the Exclusive Distributor for ViewRay's MRI-Guided Radiation Therapy System in Japan 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 2ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 3ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 4ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 5ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 6ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 7ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 8ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 9ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 10ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2015 11
... VHD was the first ... bleeding after diagnostic and ... procedures. It is a ... approved for immediate sheath ...
... absorbable collagen hemostat. FirstStop is a non-friable, ... removal characteristics. It can easily be cut ... wound. FirstStop products are not dispersed when ... after hemostasis is achieved. As the collagen ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
Medicine Products: